NCT02871401 A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1
NCT02848625 Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT02846324 Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF Status COMPLETED Phase PHASE2
NCT02827734 Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) Status UNKNOWN Phase N/A
NCT02821039 Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study Status TERMINATED Phase N/A
NCT02818712 Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up Status COMPLETED Phase N/A
NCT02803580 IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT02802345 Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment Status COMPLETED Phase PHASE3
NCT02788474 Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment Status COMPLETED Phase PHASE4
NCT02772549 Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02755441 Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02745184 Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT02739165 Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3
NCT02738801 Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT02707640 A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT02699879 Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase N/A
NCT02688647 A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT02648048 A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT02632123 Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A